Commercial peptidoglycan preparations are contaminated with superantigen-like activity that stimulates IL-17 production (Q40054411)

https://api.crossref.org/works/10.1189%2FJLB.0807588

NLRs join TLRs as innate sensors of pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0807588

Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0807588

Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0807588

Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0807588

Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0807588

Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0807588

Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0807588

Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0807588

Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0807588

21 January 2018

Bacterial superantigens

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0807588

HLA transgenic mice provide evidence for a direct and dominant role of HLA class II variation in modulating the severity of streptococcal sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0807588

Inhibition of bacterial superantigens by peptides and antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0807588

Innate immune response to Francisella tularensis is mediated by TLR2 and caspase-1 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0807588

IL-10 released by concomitant TLR2 stimulation blocks the induction of a subset of Th1 cytokines that are specifically induced by TLR4 or TLR3 in human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0807588

Cryopyrin activates the inflammasome in response to toxins and ATP

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0807588

Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment]

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0807588

The TCR Vbeta signature of bacterial superantigens spreads with stimulus strength

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0807588

The staphylococcal enterotoxins and their relatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0807588

Peptidoglycan--an endotoxin in its own right?

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0807588

Interleukin-17 family and IL-17 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0807588

Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0807588

The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0807588

IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0807588

Requirement of IL-17 receptor signaling in radiation-resistant cells in the joint for full progression of destructive synovitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0807588

Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0807588

Long term treatment of rheumatoid arthritis with high doses of intravenous immunoglobulins: effects on disease activity and serum cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0807588